U-Neuron Biomedical (ROCO:6973) Research & Development: NT$76.22 Mil (TTM As of Dec. 2025)


ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
12 GF Score
Price NT$33.75
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical Research & Development?

U-Neuron Biomedical ROCO:6973 12 Research & Development is NT$76.22 Mil as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. U-Neuron Biomedical's Research & Development for the six months ended in Dec. 2025 was NT$40.37 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$76.22 Mil.

U-Neuron Biomedical  (ROCO:6973) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

U-Neuron Biomedical Research & Development Related Terms

U-Neuron Biomedical Research & Development Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Research & Development Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 26.48 46.77 77.31 77.94 76.22

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.29 38.59 39.35 35.84 40.37
ROCO:6973
12GF Score
U-Neuron Biomedical Inc ROCO:6973
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$76.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$76.22 Mil mean?
U-Neuron Biomedical (ROCO:6973) has a Research & Development of NT$76.22 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on U-Neuron Biomedical and its competitors.
Is U-Neuron Biomedical's Research & Development too high?
U-Neuron Biomedical's current Research & Development is NT$76.22 Mil. Overall, U-Neuron Biomedical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's Research & Development compare to VRTX and REGN?
U-Neuron Biomedical's Research & Development of NT$76.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current Research & Development is NT$76.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current Research & Development of NT$76.22 Mil. The current Research & Development is NT$76.22 Mil. U-Neuron Biomedical's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current Research & Development is NT$76.22 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
12GF Score

Get the complete analysis for ROCO:6973

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.75
Price